Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prenatal exposure to valproate and risk of congenital malformations—Could we have known earlier?—A population‐based cohort study

28 Sept 2021

Abstract excerpt

OBJECTIVE: Prenatal exposure to the antiseizure medication (ASM) valproate is associated with an increased risk of congenital malformations, but warnings against the use of valproate in pregnancy were not issued until 2009. The objective was to study how early administrative health registers could have identified the teratogenic risk associated with valproate. METHODS: This was a population-based cohort study of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Maternal Mental Health During Pregnancy and Postpartum
Share to Pharmacological Effects and Toxicity Studies
Share to Pregnancy and Medication Impact

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34585373
DOI: 10.1111/epi.17085

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prenatal exposure to valproate and risk of congenital malformations—Could we have known earlier?—A population‐based cohort studyPMID 34585373Read ↗

Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomesSemantic proximity Read ↗

Transgenerational adverse effects of valproate? A patient report from 90 affected familiesSemantic proximity Read ↗

In utero exposure to antiepileptic drugs is associated with learning disabilities among offspringSemantic proximity Read ↗

Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual DisabilitySemantic proximity Read ↗

Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the childSemantic proximity Read ↗

Valproate teratogenicity and epilepsy syndromeSemantic proximity Read ↗

Antiepileptic medication during pregnancy: does fetal genotype affect outcome?Semantic proximity Read ↗

Risk of Adverse Pregnancy Outcomes Associated with Sodium Valproate(VPA): A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read ↗

Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in DenmarkSemantic proximity Read ↗

Reported congenital malformations after exposure to non-tumour necrosis factor inhibitors: a retrospective comparative study in EudraVigilanceSemantic proximity Read ↗

Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspringSemantic proximity Read ↗

Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.